DETROL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Detrol, and what generic alternatives are available?
Detrol is a drug marketed by Upjohn and is included in two NDAs.
The generic ingredient in DETROL is tolterodine tartrate. There are twenty-three drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the tolterodine tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Detrol
A generic version of DETROL was approved as tolterodine tartrate by IVAX SUB TEVA PHARMS on February 23rd, 2015.
Summary for DETROL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 79 |
Clinical Trials: | 16 |
Patent Applications: | 57 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for DETROL |
Drug Sales Revenues: | Drug sales revenues for DETROL |
What excipients (inactive ingredients) are in DETROL? | DETROL excipients list |
DailyMed Link: | DETROL at DailyMed |
Recent Clinical Trials for DETROL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of California, San Francisco | Phase 4 |
Astellas Scientific & Medical Affairs, Inc. | |
Astellas Pharma Global Development, Inc. | Phase 4 |
Pharmacology for DETROL
Drug Class | Cholinergic Muscarinic Antagonist |
Mechanism of Action | Cholinergic Muscarinic Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for DETROL
US Patents and Regulatory Information for DETROL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Upjohn | DETROL | tolterodine tartrate | TABLET;ORAL | 020771-001 | Mar 25, 1998 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Upjohn | DETROL LA | tolterodine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 021228-002 | Dec 22, 2000 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Upjohn | DETROL | tolterodine tartrate | TABLET;ORAL | 020771-002 | Mar 25, 1998 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Upjohn | DETROL LA | tolterodine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 021228-001 | Dec 22, 2000 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DETROL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Upjohn | DETROL | tolterodine tartrate | TABLET;ORAL | 020771-002 | Mar 25, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
Upjohn | DETROL | tolterodine tartrate | TABLET;ORAL | 020771-002 | Mar 25, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
Upjohn | DETROL | tolterodine tartrate | TABLET;ORAL | 020771-002 | Mar 25, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
Upjohn | DETROL | tolterodine tartrate | TABLET;ORAL | 020771-001 | Mar 25, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
Upjohn | DETROL | tolterodine tartrate | TABLET;ORAL | 020771-001 | Mar 25, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DETROL
See the table below for patents covering DETROL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 69317898 | ⤷ Try a Trial | |
Japan | 3934186 | ⤷ Try a Trial | |
Japan | H03503163 | ⤷ Try a Trial | |
Germany | 69620713 | ⤷ Try a Trial | |
Sweden | 8800207 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for DETROL
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0325571 | SPC/GB98/027 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: TOLTERODINE OPTIONALLY IN THE FORM OF PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: SE 13475 19970905; SE 13476 19970905; UK 00032/0222 19980203; UK 00032/0223 19980203 |
0325571 | C980020 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: TOLTERODINE, DESGEWENST IN DE VORM VAN EEN ZOUT MET EEN FYSIOLO GISCH ACCEPTABEL ZUUR, IN HET BIJZONDER TOLTERODINE L-TARTRAAT; NAT. REGISTRATION NO/DATE: RVG 22148, RVG 22149 19980217; FIRST REGISTRATION: SE 13475, 13476 19970905 |
0325571 | 21/1998 | Austria | ⤷ Try a Trial | PRODUCT NAME: TOLTERODIN, SEINE SALZE, RACEMATE UND ENANTIOMERE; NAT. REGISTRATION NO/DATE: 1-22389 UND 1-22390 19980210; FIRST REGISTRATION: SE 13475 UND 13476 19970905 |
0325571 | 1998C0031 | Belgium | ⤷ Try a Trial | PRODUCT NAME: TOLTERODINI-L-TARTRAS (=TOLTERODINUM); NATL REGISTRATION NO/DATE: 277 IS 301 F 3 19980309; FIRST REGISTRATION: SE 13475 19970905 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |